Rentokil Initial (LON:RTO) had its price objective boosted by JPMorgan Chase & Co. from GBX 375 ($4.90) to GBX 395 ($5.16) in a report published on Tuesday, May 7th, ThisIsMoney.Co.Uk reports. The brokerage currently has an overweight rating on the stock.
Several other research analysts have also issued reports on the company. Peel Hunt reissued a hold rating on shares of Rentokil Initial in a research report on Tuesday, April 30th. Jefferies Financial Group reaffirmed a hold rating on shares of Rentokil Initial in a research report on Tuesday, April 9th. Goldman Sachs Group cut their target price on Rentokil Initial from GBX 420 ($5.49) to GBX 400 ($5.23) and set a neutral rating on the stock in a research note on Monday, March 18th. Finally, Deutsche Bank reiterated a hold rating on shares of Rentokil Initial in a research note on Friday, March 1st. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of GBX 381.10 ($4.98).
RTO traded down GBX 3.40 ($0.04) during midday trading on Tuesday, reaching GBX 375 ($4.90). 8,500,199 shares of the company’s stock traded hands, compared to its average volume of 7,450,000. The firm has a market capitalization of $6.88 billion and a price-to-earnings ratio of -70.75. The company has a debt-to-equity ratio of 152.01, a current ratio of 0.88 and a quick ratio of 0.72. Rentokil Initial has a 52 week low of GBX 280 ($3.66) and a 52 week high of GBX 393.80 ($5.15).
Rentokil Initial Company Profile
Rentokil Initial plc, through its subsidiaries, provides route-based services in North America, the United Kingdom, Europe, Asia, Pacific, and rest of world. It offers a range of pest control services from rodents to flying insects, as well as to other forms of wildlife management for commercial and residential customers.
Recommended Story: Do back-end load funds outperform no-load funds?
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.